Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Cipher, Ranbaxy settle patent litigation with Actavis

the three companies have entered into a non-exclusive license agreement with Actavis under which Actavis may begin selling its generic version of Absorica in the US.

Excluding India, emerging markets account for about a quarter of Glenmark's total sales, and have been a driver of margin growth in the last few years.
US Food and Drug Administration's "import alert" comes two months after Canada banned Polydrug Laboratories' Ambernath manufacturing plant, citing data integrity issues.
Drugmaker Abbott Healthcare is challenging West Bengal's accusation that a sample of the company's cough syrup contained excessive levels of codeine.
Pfizer is reviewing its options for further action, a Mumbai-based company spokesman said in an emailed statement.
Cipla is buying InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, which had combined sales of $225 million in the twelve months to June 2015.
SME banne